Skip to main content
Year archive

Hansa Biopharma — 2019 filings

All 41 regulatory filings released by Hansa Biopharma (HNSA) in 2019, sourced directly from the official regulator.

41 Filings
2019 Period
2019 filings (41)
Filing Released Lang
Hansa Biopharma har nått en överenskommelse med FDA om vägen framåt mot marknadsgodkännande för imlifidase vid njurtransplantation av högsensitiserade patienter i USA
Regulatory Filings
2019-12-13 Swedish
Hansa Biopharma has agreed with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S.
Regulatory Filings
2019-12-13 English
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-10-31 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-10-31 English
Ökning av antalet aktier och röster i Hansa Biopharma
Share Issue/Capital Change
2019-09-30 Swedish
Increase of number of shares and votes in Hansa Biopharma AB
Share Issue/Capital Change
2019-09-30 English
Hansa Biopharma confirms follow-up meeting with FDA
Legal Proceedings Report
2019-09-25 English
Hansa Biopharma bekräftar uppföljningsmöte med FDA
Legal Proceedings Report
2019-09-25 Swedish
Hansa Biopharma: Emission och återköp av C-aktier för incitamentsprogram
Share Issue/Capital Change
2019-09-02 Swedish
Hansa Biopharma: Issue and re-purchase of class C shares for incentive programme
Share Issue/Capital Change
2019-09-02 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q2 2019
2019-07-18 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-07-18 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-05-27 English
Kommuniké från årsstämma i Hansa Biopharma AB (publ)
AGM Information
2019-05-22 Swedish
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
AGM Information
2019-05-22 English
Hansa Biopharma Announces Upcoming Presentations at the 2019 American Transplant Congress
Report Publication Announcement
2019-05-02 English
Hansa Biopharma tillkännager kommande presentationer vid 2019 American Transplant Congress
Report Publication Announcement
2019-05-02 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-29 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-29 English
Notice to Annual General Meeting in Hansa Biopharma AB (publ)
AGM Information
2019-04-17 English
Kallelse till årsstämma i Hansa Biopharma AB (publ)
AGM Information
2019-04-17 Swedish
Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Guillain Barré Syndrome
Regulatory Filings
2019-04-15 English
Hansa Biopharma har fått godkänt att starta fas 2-studie med imlifidase i Guillain Barrés syndrom
Regulatory Filings
2019-04-15 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-15 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-15 English
Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of imlifidase in Acute Antibody Mediated Rejection in Kidney Transplantation
Regulatory Filings
2019-03-26 English
Hansa Biopharma har fått godkänt att starta fas 2 studie med imlifidase i akut antikroppsmedierad avstötning i samband med njurtransplantation
Regulatory Filings
2019-03-26 Swedish
Hansa Biopharma Announces Selection of NiceR Lead Candidate
Regulatory Filings
2019-03-21 English
Hansa Biopharma tillkännager val av ny läkemedelskandidat ur utvecklingsprogrammet NiceR
Regulatory Filings
2019-03-21 Swedish
Europeiska läkemedelsmyndigheten har accepterat Hansa Biopharmas ansökan om marknadsgodkännande för IDEFIRIX™ (imlifidase)
Regulatory Filings
2019-03-01 Swedish
Hansa Biopharma Announces European Medicines Agency Accepts Marketing Authorization Application for IDEFIRIX™ (imlifidase)
Regulatory Filings
2019-03-01 English
Ökning av antalet aktier och röster i Hansa Biopharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-02-28 Swedish
Increase of number of shares and votes in Hansa Biopharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-02-28 English
Earnings Release 2018
Earnings Release FY 2018
2019-02-08 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q4 2018
2019-02-08 English
Hansa Biopharma appoints Donato Spota as new Chief Financial Officer
Board/Management Information
2019-02-07 English
Hansa Biopharma utser Donato Spota till ny Chief Financial Officer
Board/Management Information
2019-02-07 Swedish
Ökning av antalet röster i Hansa Medical AB (publ)
Share Issue/Capital Change
2019-01-31 Swedish
Increase of number of votes in Hansa Medical AB (publ)
Share Issue/Capital Change
2019-01-31 English
Hansa Medical AB Provides Regulatory Update for Imlifidase in Kidney Transplantation
Regulatory Filings
2019-01-15 English
Hansa Medical AB ger uppdatering gällande möten med regulatoriska myndigheter för imlifidase vid njurtransplantation
Legal Proceedings Report
2019-01-15 Swedish